Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Milanés Virelles, María T ^a   García García, Idrian ^b   Santos Herrera, Yamilet ^c   Valdés Quintana, Magalys ^a   Valenzuela Silva, Carmen M ^b   Jiménez Madrigal, Gaspar ^c   Ramos Gómez, Thelvia I ^b   Bello Rivero, Iraldo ^b   Fernández Olivera, Norma ^a   Sánchez de la Osa, Reinaldo B ^d   Rodríguez Acosta, Carmen ^a   González Méndez, Lidia ^b   Martínez Sánchez, Gregorio ^a   López Saura, Pedro A ^b  

^a Hospital Neumologico Benefico Juridico   (Cuba)

^b Center for Biological Research Cuba   (Cuba)

^c Hospital Amalia Simoni   (Cuba)

^d UNIVERSITY OF HAVANA   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CYTOKINE; ETHAMBUTOL; PLACEBO; RECOMBINANT GAMMA INTERFERON; RIFAMPICIN; TRANSFORMING GROWTH FACTOR BETA; IMMUNOLOGICAL ADJUVANT;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ANOREXIA; ARTHRALGIA; ARTICLE; ASTHENIA; BACTERIUM CULTURE; BLOOD SMEAR; CHILL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEPRESSION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG TOLERABILITY; EPIGASTRIC PAIN; ETHNICITY; FEMALE; FEVER; FLU LIKE SYNDROME; HUMAN; IMAGE ANALYSIS; INJECTION SITE PAIN; LUNG INFECTION; MALE; MORTALITY; MYALGIA; MYCOBACTERIOSIS; NAUSEA; OXIDATIVE STRESS; PERIPHERAL EDEMA; PROTEIN DETERMINATION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEDIMENTATION RATE; SEX DIFFERENCE; SIDE EFFECT; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TREATMENT DURATION; VOMITING; ATYPICAL MYCOBACTERIOSIS; BLOOD; CUBA; DRUG THERAPY; IMMUNOLOGY; LUNG; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM INTRACELLULARE AVIUM; PATHOLOGY; SPUTUM;

ADJUVANTS, IMMUNOLOGIC; AGED; CUBA; CYTOKINES; DOUBLE-BLIND METHOD; DRUG THERAPY; FEMALE; HUMANS; INTERFERON-GAMMA, RECOMBINANT; LUNG; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM INFECTIONS, ATYPICAL; OXIDATIVE STRESS; SPUTUM;

EID: 41549161578     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-17     Document Type: Article

References (52)

1. Gordin FM Horsburgh CR Jr Mycobacterium avium Complex. Infections Caused by Nontuberculous Mycobacteria Mandell, Bennett, & Dolin: Principles and Practice of Infectious Diseases. Chapters 250-251 Copyright © 2005 Churchill Livingstone. Orlando: W.B. Saunders, An imprint of Elsevier Brown-Elliott BA, Wallace RJ Jr 2897-2916.
2. Prince DS Peterson DD Steiner RM Gottlieb JE Scott R Israel HL Figueroa WG Fish JE Infection with Mycobacterium avium complex in patients without predisposing conditions N Engl J Med 1989, 321:863-8. 2770822
3. Gomes MS Paul S Moreira AL Appelberg R Rabinovitch M Kaplan G Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages Infect Immun 1999, 67:3199-206. 116496 10377091
4. Pietersen R Thilo L de Chastellier C Mycobacterium tuberculosis and Mycobacterium avium modify the composition of the phagosomal membrane in infected macrophages by selective depletion of cell surface-derived glycoconjugates Eur J Cell Biol 2004, 83:153-8. 10.1078/0171-9335-00370 15260437
5. Griffith DE Brown BA Girard WM Wallace RJ Jr Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease Clin Infect Dis 1995, 21:594-8. 8527549
6. Griffith DE Brown-Elliott BA Shepherd S McLarty J Griffith L Wallace RJ Jr Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease Am J Respir Crit Care Med 2005, 172:250-3. 10.1164/rccm.200407-863OC 15860751
7. Benson CA Williams PL Currier JS Holland F Mahon LF MacGregor RR Inderlied CB Flexner C Neidig J Chaisson R Notario GF Hafner R AIDS Clinical Trials Group 223 Protocol Team A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome Clin Infect Dis 2003, 37:1234-43. 10.1086/ 378807 14557969
8. Wang J Wakeham J Harkness R Xing Z Macrophages are a significant source of type 1 cytokines during mycobacterial infection J Clin Invest 1999, 103:1023-9. 408266 10194475 10.1172/JCI4431
9. Holland SM Immunotherapy of mycobacterial infections Semin Respir Infect 2001, 16:47-59. 11309712
10. Hallstrand TS Ochs HD Zhu Q Liles WC Inhaled IFN-gamma for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-gamma deficiency Eur Respir J 2004, 24:367-70. 10.1183/ 09031936.04.00036704 15358692
11. Guide SV Holland SM Host susceptibility factors in mycobacterial infection. Genetics and body morphotype Infect Dis Clin North Am 2002, 16:163-86. 10.1016/S0891-5520(03)00051-5 11917812
12. Dorman SE Picard C Lammas D Heyne K van Dissel JT Baretto R Rosenzweig SD Newport M Levin M Roesler J Kumararatne D Casanova JL Holland SM Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies Lancet 2004, 364:2113-21. 10.1016/S0140-6736(04)17552-1 15589309
13. Muszlak M Chapgier A Barry Harivelo R Castella C Cremades F Goulois E Laporte R Casanova JL Ranaivoarivony V Hebert JC Santiago J Picard C Multifocal infection due to Mycobacterium intracellulare: First case of interferon gamma receptor partial dominant deficiency in tropical French territory Arch Pediatr 2007, 14(3):270-272. Epub 2007 Jan 12 17223023 10.1016/j.arcped.2006.11.023
14. Harrop AR Ghahary A Scott PG Forsyth N Friedland A Tredget EE Effect of γ interferon on cell proliferation, collagen production and procollagen mRNA expression in hypertrophic scar fibroblast in vitro J Surg Res 1995, 58:471-7. 10.1006/jsre.1995.1074 7745958
15. Ulloa L Doody J Massague J Inhibition of transforming growth factor-beta/ SMAD signaling by the interferon-gamma/STAT pathway Nature 1999, 397:710-3. 10.1038/17826 10067896
16. Squires KE Brown ST Armstrong D Murphy WF Murray HW Interferon-gamma treatment for Mycobacterium avium-intracellulare complex bacillemia in patients with AIDS J Infect Dis 1992, 166:686-7. 1500760
17. Holland SM Eisenstein EM Kuhns DB Turner ML Fleisher TA Strober W Gallin JI Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report N Engl J Med 1994, 330:1348-55. 10.1056/NEJM199405123301904 7908719
18. Levin M Newport MJ D'Souza S Kalabalikis P Brown IN Lenicker HM Agius PV Davies EG Thrasher A Klein N Familial disseminated atypical mycobacterial infection in childhood: A human mycobacterial susceptibility gene? Lancet 1995, 345:79-83. 10.1016/ S0140-6736(95)90059-4 7815885
19. Chatte G Panteix G Perrin-Fayolle M Pacheco Y Aerosolized interferon gamma for Mycobacterium avium -complex lung disease Am J Respir Crit Care Med 1995, 152:1094-6. 7663788
20. Holland SM Therapy of mycobacterial infections Res Immunol 1996, 147:572-81. 10.1016/S0923-2494(97)85224-8 9127890
21. Boehringer Mannheim. Biochemical information A revised biochemical reference source. Enzymes for routine Germany: Boehringer Mannheim 1 1987, 15-16.
22. Esterbauer H Cheeseman KH Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal Methods Enzymol 1990, 186:407-21. 2233308
23. Ozdermirler G Mehmetcik G Oztezcan S Peroxidation and antioxidant activity of serum in patients with Diabetes Mellitus and Myocardial Infarction Horm Metabol Res 1995, 27(4):194-6. 7750904
24. Shukla GS Hussain T Chandra SV Possible role of superoxide dismutase activity and lipid peroxide levels in cadmium neurotoxicity: In vivo and in vitro studies in growing rats Life Sci 1987, 14:2215-25. 10.1016/ 0024-3205(87)90518-2
25. Witko-Sarsat V Friedlander M Nguyen Khoa T Capeillere-Blandin C Nguyen AT Canteloup S Dayer JM Jungers P Drueke T Descamps-Latscha B Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure J Immunol 1998, 161:2524-32. 9725252
26. Martinez-Sanchez G Al-Dalain SM Menendez S Re L Giuliani A Candelario-Jalil E Alvarez H Fernandez-Montequin JI Leon OS Therapeutic efficacy of ozone in patients with diabetic foot Eur J Pharmacol 2005, 523:151-61. 10.1016/j.ejphar.2005.08.020 16198334
27. Hoflich C Sabat R Rosseau S Temmesfeld B Slevogt H Docke WD Grutz G Meisel C Halle E Gobel UB Volk HD Suttorp N Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans Blood 2004, 103:673-5. 10.1182/ blood-2003-04-1065 12947000
28. Field SK Fisher D Cowie RL Mycobacterium avium complex pulmonary disease in patients without HIV infection Chest 2004, 126:566-81. 10.1378/ chest.126.2.566 15302746
29. Vial T Descotes J Clinical toxicity of the interferons Drug Saf 1994, 10:115-50. 10.2165/00002018-199410020-00003 7516663
30. Appelberg R Castro AG Pedrosa J Silva RA Orme IM Minoprio P Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection Infect Immun 1994, 62:3962-71. 303054 8063414
31. Saunders BM Cheers C Inflammatory response following intranasal infection with Mycobacterium avium complex: Role of T-cell subsets and gamma interferon Infect Immun 1995, 63:2282-7. 173298 7768610
32. Xu YD Hua J Mui A O'Connor R Grotendorst G Khalil N Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol 2003, 285:L527-39. 12598227
33. Pilette C Fort J Rifflet H Cales P Anti-fibrotic effects of interferons. Mechanisms of action and therapeutic prospects Gastroenterol Clin Biol 1997, 21:466-71. 9295973
34. Raghu G Brown KK Bradford WZ Starko K Noble PW Schwartz DA King TE Jr Idiopathic Pulmonary Fibrosis Study Group A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis N Engl J Med 2004, 350:125-33. 10.1056/NEJMoa030511 14711911
35. Antoniou KM Nicholson AG Dimadi M Malagari K Latsi P Rapti A Tzanakis N Trigidou R Polychronopoulos V Bouros D Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis Eur Respir J 2006, 28:496-504. 10.1183/09031936.06.00032605 16611657
36. Nathan CF Kaplan G Levis WR Nusrat A Witmer MD Sherwin SA Job CK Horowitz CR Steinman RM Cohn ZA Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy N Engl J Med 1986, 315:6-15. 3086725
37. Sundar S Rosenkaimer F Murray HW Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma J Infect Dis 1994, 170:659-62. 8077725
38. Raad I Hachem R Leeds N Sawaya R Salem Z Atweh S Use of adjunctive treatment with interferon-gamma in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain Clin Infect Dis 1996, 22:572-4. 8852983
39. Condos R Rom WN Schulger NW Treatment of multidrug-resistant tuberculosis with interferon γ via aerosol Lancet 1997, 349:1513-15. 10.1016/S0140-6736(96)12273-X 9167461
40. Koh WJ Kwon OJ Suh GY Chung MP Kim H Lee NY Kim TS Lee KS Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis J Korean Med Sci 2004, 19:167-71. 15082886
41. Suarez-Mendez R Garcia-Garcia I Fernandez-Olivera N Valdes-Quintana M Milanes-Virelles MT Carbonell D Machado-Molina D Valenzuela-Silva CM Lopez-Saura PA Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: A pilot study BMC Infect Dis 2004, 4:44. 529257 15500691 10.1186/1471-2334-4-44
42. Remiszewski P Roszkowska-Sliz B Winek J Chapgier A Feinberg J Langfort R Bestry I Augustynowicz-Kopec E Ptak J Casanova JL Rowinska-Zakrzewska E Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFNgammaR1 deficiency Respiration 2006, 73:375-8. 10.1159/000088682 16195661
43. Patel SY Ding L Brown MR Lantz L Gay T Cohen S Martyak LA Kubak B Holland SM Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections J Immunol 2005, 175:4769-76. 16177125
44. Lam PK Griffith DE Aksamit TR Ruoss SJ Garay SM Daley CL Catanzaro A Factors Related to Response to Intermittent Treatment of Mycobacterium avium Complex Lung Disease Am J Respir Crit Care Med 2006, 173:1283-9. 10.1164/rccm.200509-1531OC 16514112
45. Macdonald J Galley HF Webster NR Oxidative stress and gene expression in sepsis Br J Anaesth 2003, 90:221-32. 10.1093/bja/aeg034 12538380
46. Yazici C Kose K Calis M DemIr M Kirnap M Ates F Increased advanced oxidation protein products in Behcet's disease: A new activity marker? Br J Dermatol 2004, 151:105-11. 10.1111/j.1365-2133.2004.06003.x 15270878
47. Requena JR Levine RL Stadtman ER Recent advances in the analysis of oxidized proteins Amino Acids 2003, 25:221-6. 10.1007/s00726-003-0012-1 14661085
48. Harth G Horwitz MA Export of recombinant Mycobacterium tuberculosis superoxide dismutase is dependent upon both information in the protein and mycobacterial export machinery. A model for studying export of leaderless proteins by pathogenic mycobacteria J Biol Chem 1999, 274:4281-92. 10.1074/jbc.274.7.4281 9933629
49. Lee YJ Han Y Lu HT Nguyen V Qin H Howe PH Hocevar BA Boss JM Ransohoff RM Benveniste EN TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression J Immunol 1997, 158:2065-75. 9036950
50. Hale-Donze H Greenwell-Wild T Mizel D Doherty TM Chatterjee D Orenstein JM Wahl SM Mycobacterium avium complex promotes recruitment of monocyte hosts for HIV-1 and bacteria J Immunol 2002, 169:3854-62. 12244182
51. Chensue SW Warmington KS Ruth JH Sanghi PS Lincoln P Kunkel SL Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: Relationship to local inflammation, Th cell expression, and IL-12 production J Immunol 1996, 157:4602-8. 8906839
52. Muhl H Pfeilschifter J Anti-inflammatory properties of pro-inflammatory interferon-gamma Int Immunopharmacol 2003, 3:1247-55. 10.1016/ S1567-5769(03)00131-0 12890422